Guidelines for safe return to physical activity after COVID infection

Authors

  • Diego Botta Galenos Medical Center, Neuquén, Argentina
  • Fernando Krynski Fernández Hospital, Autonomous City of Buenos Aires, Argentina
  • Julio Szuster Milstein Hospital, Autonomous City of Buenos Aires, Argentina
  • Susana Apoloni Austral University Hospital, Pilar, Province of Buenos Aires, Argentina
  • Débora Hernández Austral University Hospital, Pilar, Province of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v56i2Sup.536

Keywords:

physical activity, diabetes mellitus, COVID infection

Abstract

COVID 19 infection can affect various organs, including the cardiovascular and pulmonary systems, which poses a challenge when restarting physical activity (PA) in previously active people.
In this document, the risk assessment algorithms are reviewed and a proposal for a safe return to PA is described.

Author Biographies

Diego Botta, Galenos Medical Center, Neuquén, Argentina

Diabetologist Doctor

Fernando Krynski, Fernández Hospital, Autonomous City of Buenos Aires, Argentina

Medical, Nutrition and Diabetes Service

Julio Szuster, Milstein Hospital, Autonomous City of Buenos Aires, Argentina

Nutrition specialist doctor

Susana Apoloni, Austral University Hospital, Pilar, Province of Buenos Aires, Argentina

Medical specialist in Clinical and Nutrition, specialized in Diabetes, Argentine Diabetes Society (SAD); Coordinator of the SAD Physical Activity Committee; Diabetes Service Staff

Débora Hernández, Austral University Hospital, Pilar, Province of Buenos Aires, Argentina

Medical specialist in Clinical and Nutrition, specialized in Diabetes, Argentine Diabetes Society (SAD); Secretary of the SAD Physical Activity Committee; Diabetes Service Staff, Austral University Hospital, Primary Care Centers No. 18 (CeSAC)

References

I. Mattiuzzi C, Lippi G. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med 2020 Feb;8(3):48.

II. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020 Feb 15;395(10223):497-506.

III. Tajbakhsh A, Gheibi-Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, Johnston TP, Sahebkar A. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. 2021 Mar;19(3):345-357. doi: 10.1080/14787210.2020.1822737. Epub 2020 Sep 28. PMID: 32921216.

IV. Wei ZY, Qian HY. Myocardial injury in patients with COVID-19 pneumonia. Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 2;48:E006.

V. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020 Feb 15;395(10223):514-523

VI. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020 Feb;323(11):1061-1069.

VII. Wilson MG, Hull JH, Rogers J, Pollock N, Dodd M, Haines J, Harris S, Loosemore M, Malhotra A, Pieles G, Shah A, Taylor L, Vyas A, Haddad FS, Sharma S. Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians. Br J Sports Med 2020 Oct;54(19):1157-1161

VIII. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan. China: A single-centered, retrospective, observational study. Lancet Respir Med 2020;8:475- 481

IX. De Almeida-Pititto B, Dualib PM, Zajdenverg L, Rodrigues-Dantas J, Dias de Souza F, Rodacki M. Severity and mortality of COVID-19 in patients with diabetes, hypertension and cardiovascular disease: A meta-analysis. Diabetol Metab Syndr 2020;12:75.

X. Carfì A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-acute care study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603-5.

XI. Baggish A, Drezner JA, Kim J, Martínez M, Prutkin JM. Resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes. Br J Sports Med 2020 Oct;54(19):1130-1131.

XII. Metzl JD, McElheny K, Robinson JN, Scott DA, Sutton KM, Toresdahl BG. Considerations for return to exercise following mild-to-moderate COVID-19 in the recreational athlete. HSS J 2020;16(Suppl1):102-107.

XIII. Jewson J, McNamara A, Fitzpatrick J. Life after COVID-19: The importance of a safe return to physical activity. Aust J Gen Pract 2020;49 Suppl40. doi: 10.31128/AJGP-COVID-40.

XIV. Salman D, Vishnubala D, Le Feuvre P, Beaney T, Korgaonkar J, Majeed A, et al. Returning to physical activity after COVID-19. BMJ 2021;372:m4721 doi:10.1136/bmj.m4721.

XV. de Vries ST, Bijsterveld N, et al. Return to sports after COVID-19: a position paper from the Dutch Sports Cardiology Section of the Netherlands Society of Cardiology. Neth Heart J 2020;28(7-8):391-395. doi:10.1007/s12471-020-01469.

Published

2022-08-01

How to Cite

Botta, D., Krynski, F., Szuster, J., Apoloni, S., & Hernández, D. (2022). Guidelines for safe return to physical activity after COVID infection. Journal of the Argentine Society of Diabetes, 56(2Sup), 40–43. https://doi.org/10.47196/diab.v56i2Sup.536

Issue

Section

Recommendations

Most read articles by the same author(s)

1 2 > >>